Overview of Fetomaternal Hemorrhage

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 180 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Hemolytic Disease of the Fetus and Newborn. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Hemolytic Disease of the Fetus and Newborn (online CE course)
Overview of Fetomaternal Hemorrhage

Fetomaternal hemorrhage (FMH) greater than 30 mL of whole blood occurs in only about 0.3% of cases but must be detected to prevent the mother from producing anti-D. Once the mother has become immunized to D, RhIG is of no use.
A typical test protocol is to first screen for a large FMH and then quantify the bleed if the screen is positive. Some laboratories proceed directly to a test that can quantitate the size of the FMH.
Once the size of the FMH is determined, a formula is used to determine how much RhIG is needed. Recall that:
  • A standard vial of RhIG contains 1500 IU (300 µg) of IgG anti-D.
  • 300 µg of RhIG can suppress immunization to approximately 30 mL of D-positive whole blood.